← Back to News

Daily IV Report

Mid-session IV Report March 31, 2026

Mid-session IV Report March 31, 2026 The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By monitoring this market data, traders can create strategies that capitalize on this often over looked information Options with increasing option implied volatility: FUBO METU CAR CMG […]

By Market Rebellion · March 31, 2026
Mid-session IV Report March 31, 2026

Mid-session IV Report March 31, 2026

The following report is a snapshot of noteworthy changes in stock and option volumes, as well as changes in option implied volatilities. By monitoring this market data, traders can create strategies that capitalize on this often over looked information

Options with increasing option implied volatility: FUBO METU CAR CMG SPOT META SBUX AMZN SYY MSFT WBD MLTX CAG LW

Popular stocks with increasing option volume: MU SOFI AMD NFLX CRWV MSTR INTC PLTR AVGO MRVL AAL

Active options: NVDA TSLA MU META AMZN MSFT AAPL SOFI AMD NFLX GOOGL CRWV MSTR INTC PLTR GME AVGO MRVL AAL GOOG

Movement

Eli Lilly & Co. (LLY) Lilly 30-day option implied volatility is at 48; compared to its 52-week range of 27 to 64. Call put ratio 2.8 calls to 1 put after acquiring Centessa (CNTA) for $38/share in cash plus one CVR.

Centessa Pharmaceuticals (CNTA) 30-day option implied volatility is at 12; compared to its 52-week range of 65 to 216. Call put ratio 3.7 calls to 1 put after Eli Lilly (LLY) acquiring Centessa for $38/share in cash plus one CVR.

Novo Nordisk (NVO) 30-day option implied volatility is at 45; compared to its 52-week range of 36 to 70. Call put ratio 1.2 calls to 1 put after launches multi-month subscription program for Wegovy.

Marvell Technology (MRVL) 30-day option implied volatility is at 58; compared to its 52-week range of 43 to 103. Call put ratio 1.8 calls to 1 put after Nvidia invests $2B in Marvell.

CoreWeave (CRWV) 30-day option implied volatility is at 92; compared to its 52-week range of 67 to 157. Call put ratio 1.8 calls to 1 put after closes $8.5B financing facility.

Biogen (BIIB) 30-day option implied volatility is at 40; compared to its 52-week range of 28 to 60. Call put ratio 1.6 calls to 1 put after acquiring Apellis (APLS) for $5.6B.

Apellis Pharmaceuticals (APLS) 30-day option implied volatility is at 16; compared to its 52-week range of 44 to 99. Call put ratio 1.2 calls to 1 put after Biogen (BIIB) acquired for $5.6B.

Option IV into quarter results and outlook

RH (RH) August 2 weekly call option implied volatility is at 220, April is at 120; compared to its 52-week range of 54 to 129. Call put ratio 1 call to 1.2 puts into the expected release of quarter results today after the bell.

Nike (NKE) August 2 weekly call option implied volatility is at 130, April is at 62; compared to its 52-week range of 25 to 78. Call put ratio 2.4 calls to 1 put into the expected release of quarter results after the bell after the bell on April 2.

Options with decreasing option implied volatility: WVE BRZE CGWY GME PDD
Increasing unusual option volume: PROP CORN AUTL TERN VFS WTI CANE MDGL
Increasing unusual call option volume: PROP AUTL TERN MKC PRGS CANE WTI WVE AMTX
Increasing unusual put option volume: MTUM SEI ABTC VLY WIX TSEM BANC NEBX LYV BANC INDA URI